期刊文献+

肺血栓栓塞症患者抗凝系统变化的研究 被引量:2

Changes of Anticoagulation System Changes in Patients with Pulmonary Thromboembolism
暂未订购
导出
摘要 [目的]探讨肺血栓栓塞症(PTE)患者抗凝系统的变化及其对诊断的价值。[方法]选取35例确诊的急性PTE患者和30例正常人为研究对象,分别测定血浆抗凝血酶Ⅲ活性(AT-Ⅲ)、蛋白C(PC)活性、蛋白S(PS)活性。[结果]PTE患者血浆中抗凝血酶Ⅲ活性,蛋白C活性及蛋白S活性均显著低于对照组(P<0.05);这些指标在单纯PTE组和PTE+深静脉血栓形成(DVT)组间无统计学意义;吸烟对其影响不大。[结论]PTE患者存在抗凝系统活性减低;部分患者可能存在抗凝血系统的缺陷;这些指标对于PTE的诊断有一定价值。 [Objective] To investigate the changes of anticoagulation system in patients with pulmonary thromboembolism(PTE) and evaluate its diagnostic value. [Methods] Thirty-five acute PTE and thirty healthy persons(control) were selected and the activity of antithrombin Ⅲ (AT-Ⅲ), protein C (PC)and protein S (PS) was measured respectively. [Result] The activity of AT-Ⅲ, protein C and protein S in patients with PTE was significantly lower than those of the control group (P〈0.05). The comparison of these indexes between PTE group and PTE plus deep venous thrombosis (DVT) group hadn't statistical difference and smoking had less influence. [Conclusion] The anticoagulant activity decreases in patients with PTE and some patients may have the anticoagulant system deficiency. What is more, these figures play an important role in the diagnosis of PTE.
出处 《天津中医药大学学报》 CAS 2006年第2期77-79,共3页 Journal of Tianjin University of Traditional Chinese Medicine
基金 天津市卫生局资助项目(03K227)
关键词 肺血栓栓塞症 抗凝系统 抗凝血酶-Ⅲ 蛋白C 蛋白S pulmonary thromboembolism antieoagulation system antithrombin Ⅲ protein C protein S
  • 相关文献

参考文献10

  • 1[1]Silverstein MD,Heit JA,Mohr DN,et al.Trends in the incidence of deep vein thrombosis and pulmonary embolism:a 25 year.population based study[J].Arch Intern Med,1998,158(6):585-593.
  • 2[2]Gold haber SZ,Hennekens CH,Evvans DA,et al.Factors associated with correctante mortem diagnosis of major pulmoinary embolism[J].Am J Med,1982,73(6):822-826.
  • 3李金泉,江一民,吴翼伟,崔岗,张海涛,苏成海,张玮.抗凝血酶Ⅲ测定在血栓形成性疾病中的诊断价值[J].苏州医学院学报,2000,20(6):541-542. 被引量:21
  • 4胡云建,陶凤荣,王厚东,张秀珍,赵丽,朱震宏.D-二聚体测定在肺栓塞诊断中的应用价值[J].中华检验医学杂志,2002,25(2):95-97. 被引量:143
  • 5[5]Reitsma PH,Bemardi F,Doig RG,et al.Protein C deficiency:A database of mutations,1995 update[J].Thromb Haemost,1995,73(5):876-889.
  • 6叶任高 陆再英.内科学[M].北京:人民卫生出版社,2002.216.
  • 7[7]Gandrille S,Borgel D,Ireland H,et al.Protein S deficiency:a database of mutations[J].Human Gene mutation Database.2002:341-345.
  • 8[8]包承鑫.血栓与止血·基础理论与临床[M].第2版.上海:上海科学技术出版社,1996:460-478.
  • 9[9]Folsom AR,Aleksic N,Wang L,et al.Protein C,antithrombin,and venous thromboembolism incidence:a prospective population-based study[J].Arterioscler Thromb Vasc Biol,2002,22(6):1018-1022.
  • 10[10]Yoshimura,Y Nishimura,Y Funada,et al.Pulmonary thromboembolism associated with familial protein C deficiency type I[J].Nihon Kokyuki Gakkai Zasshi,2003,41(7):451-456.

二级参考文献3

共引文献365

同被引文献37

  • 1罗佳滨,关月,马洪星,李少英,李月秋,吕学诜.凝血因子V基因点突变1691 A在不同种族人群中的分布[J].中华医学遗传学杂志,1996,13(4):219-220. 被引量:17
  • 2Suehisa E, Nomura T, Kawasaki T. Frequency of natural coagulationinhibitot ( antithrombin Ⅲ, protein C and protein S) deficiencies in Japanese patients With spontaneous deep vein thrombosis. Blood Coagulation Fibrinolysis, 2001,12:95.
  • 3LiuHW,KwongYL, BourkeC, et al. High ineidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost, 1994,71:476-419.
  • 4Dykes AC, Walker ID, McMahon AD. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sexandhormoneuse, andestimate for prevalence of deficiency state. Br J Haematol, 2001,113:636.
  • 5LefkowitzJB, ClarkeSH, Barbour LA. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol, 1996,175:657.
  • 6SimkovaM, Simko F, Kovacs L Resistance to activated p rotein C-frequent etio-logic factor for venous thrombosis. B ratisl Lek Listy,2001,102(5):240-247.
  • 7Williamson D, Brown K, Luddington R, et al. Factor V Cambridge: A new mutation(Arg306→Thr) associated with resistance to activated protein G. Blood, 1998,91:1140.
  • 8Chen WP, Lee CK, Kwong YL, et al. Anovel mutation of Arg306 of factor V gene in Hong Kong Chinese.Blood, 1998,91:1135-1139.
  • 9Castaman G, Tosetto A, Ruggen M, et al. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis. British Jhaematology, 1999,106:232-236.
  • 10Rosen SB, Sturk a. Activated protein C resistance-a major risk factor forthrombosis. Eur J Clin Chen Chin Biochem, 1997,35(7):501-516.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部